跳至主要内容
临床试验/CTRI/2026/03/106206
CTRI/2026/03/106206尚未招募不适用

To assess the effectiveness of constitutional homoeopathic treatment in case of atopic dermatitis in paediatric age group:a pre test post test interventional study

National Institute of Homoeopathy sector A-5 Choudhary ramdev chowk narela Delhi1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2026年3月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
38
试验地点
1

研究概览

简要总结

Atopic dermatitis (ICD-10 L20.9) is a chronic, non-communicable recurring skin disorder seen more commonly in infants and children but can occur in any age group. Atopic dermatitis being a chronic disease, affects the quality of life of the patient as well as the family. Although homoeopathy offers holistic care this study aims to see the utility of constitutional homoeopathic treatment in the management of atopic dermatitis. After extensive research, we could find the studies in the field of constitutional homoeopathic treatment in the case of atopic dermatitis in paediatric age group are lacking and unexplored. Atopic dermatitis often leading to significant morbidity adversely affecting a child’s quality of life and daily functioning. Constitutional homeopathic treatment may offer a safer, less invasive alternative, with a focus on tailoring remedies to the unique symptoms and constitution of each child. This personalized approach is essential in Paediatrics, where children may respond differently to treatments compared to adults. The enrollment will be done as per inclusion criteria given. The patient will be given individualized homoeopathic medicine based on symptom similarity.

Primary outcome will be accessed by SCORAD index at baseline and after 3 months of follow up, secondary outcome will be accessed by CDLQI at baseline and after 3 months of follow up and MONARCH criteria after 3 months of follow up.

Duration of intervention 3 months.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
4.00 Year(s) 至 17.00 Year(s)(—)
性别
All

入选标准

  • Participant fulfilling Hanifin and Rajka diagnostic criteria.
  • Participants belonging to mild, moderate and severe category of SCORAD Index.
  • Participants parents willing to give written informed consent and the patients willing to give verbal assent (children aged between 7-12 years) and or written assent (children aged between 12-17years).
  • Participants in the age group of 4-17 years.
  • Participants of all genders.
  • Participant already undergoing oral/topical conventional therapy for atopic dermatitis may be recruited after a washout period of 15 days.

排除标准

  • Complicated cases of atopic dermatitis like severe secondary infections.
  • Critically ill patient, immune-compromised patient.
  • Patient suffering from any other uncontrolled systemic diseases.
  • Diagnosed cases of unstable mental or psychiatric illness.
  • Patient having any substance abuse.

研究者

发起方
National Institute of Homoeopathy sector A-5 Choudhary ramdev chowk narela Delhi
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Rani Jaiswal

National Institute of Homoeopathy delhi

研究点 (1)

Loading locations...

相似试验